219 related articles for article (PubMed ID: 32294235)
1. Macrophages in the pathophysiology of NAFLD: The role of sex differences.
Ministrini S; Montecucco F; Sahebkar A; Carbone F
Eur J Clin Invest; 2020 Jun; 50(6):e13236. PubMed ID: 32294235
[TBL] [Abstract][Full Text] [Related]
2. Macrophages in metabolic associated fatty liver disease.
Alharthi J; Latchoumanin O; George J; Eslam M
World J Gastroenterol; 2020 Apr; 26(16):1861-1878. PubMed ID: 32390698
[TBL] [Abstract][Full Text] [Related]
3. Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism.
Krenkel O; Tacke F
Semin Liver Dis; 2017 Aug; 37(3):189-197. PubMed ID: 28847030
[No Abstract] [Full Text] [Related]
4. Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics.
Nagashimada M; Honda M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360773
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD).
Kragh Petersen S; Bilkei-Gorzo O; Govaere O; Härtlova A
Scand J Immunol; 2020 Nov; 92(5):e12971. PubMed ID: 32892401
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
7. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
Pierantonelli I; Svegliati-Baroni G
Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis: role of macrophages and fibroblasts in the liver.
Itoh M; Ogawa Y; Suganami T
Nagoya J Med Sci; 2020 Aug; 82(3):391-397. PubMed ID: 33132423
[TBL] [Abstract][Full Text] [Related]
11. Major roles of kupffer cells and macrophages in NAFLD development.
Park SJ; Garcia Diaz J; Um E; Hahn YS
Front Endocrinol (Lausanne); 2023; 14():1150118. PubMed ID: 37274349
[TBL] [Abstract][Full Text] [Related]
12. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
Oniciu DC; Hashiguchi T; Shibazaki Y; Bisgaier CL
PLoS One; 2018; 13(5):e0194568. PubMed ID: 29847555
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease.
Chen S; Guo H; Xie M; Zhou C; Zheng M
Int Immunopharmacol; 2021 Aug; 97():107609. PubMed ID: 33887577
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A
Nat Commun; 2021 Jan; 12(1):187. PubMed ID: 33420074
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease.
Bibbò S; Ianiro G; Dore MP; Simonelli C; Newton EE; Cammarota G
Mediators Inflamm; 2018; 2018():9321643. PubMed ID: 29563854
[TBL] [Abstract][Full Text] [Related]
16. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
17. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.
Chen D; Le TH; Shahidipour H; Read SA; Ahlenstiel G
Cells; 2019 Oct; 8(11):. PubMed ID: 31717860
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation.
Maurice JB; Garvey L; Tsochatzis EA; Wiltshire M; Cooke G; Guppy N; McDonald J; Marchesi J; Nelson M; Kelleher P; Goldin R; Thursz M; Lemoine M
AIDS; 2019 Apr; 33(5):805-814. PubMed ID: 30882489
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
[TBL] [Abstract][Full Text] [Related]
20. Autophagy in nonalcoholic steatohepatitis.
Amir M; Czaja MJ
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):159-66. PubMed ID: 21476911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
